Flora Growth (NASDAQ: FLGC) reported Q1 2024 earnings per share (EPS) of -$0.38, up 34.48% year over year. Total Flora Growth earnings for the quarter were -$3.37 million. In the same quarter last year, Flora Growth's earnings per share (EPS) was -$0.58.
As of Q2 2024, Flora Growth's earnings has grown year over year. Flora Growth's earnings in the past year totalled -$56.11 million.
What was FLGC's revenue last quarter?
Flora Growth (NASDAQ: FLGC) reported Q1 2024 revenue of $18.03 million up 6.67% year over year. In the same quarter last year, Flora Growth's revenue was $19.32 million.
What was FLGC's revenue growth in the past year?
As of Q2 2024, Flora Growth's revenue has grown 54.13% year over year. This is 44.15 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.98%. Flora Growth's revenue in the past year totalled $74.78 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.